COVID-19 | We still need to be vigilant, says Health Minister Mansukh Mandaviya

Active COVID-19 cases and positivity rate had fallen in most of the States in last two weeks

January 29, 2022 07:16 pm | Updated 07:16 pm IST - NEW DELHI

A health worker from a Primary Health Centre team arrives in Gir Forest Range on January 29, 2022.

A health worker from a Primary Health Centre team arrives in Gir Forest Range on January 29, 2022.

Union Health Minister Mansukh Mandaviya on Saturday said that though active COVID-19 cases and positivity rate had fallen in most of the States in the last two weeks, “we still need to be vigilant and not lower our guard.’’

Speaking at a virtual meeting with health ministers and senior officials of Odisha, Bihar, Chhattisgarh, Jharkhand and West Bengal on Saturday he urged them to monitorthe casepositivity rate onadaily basis and increase the RT-PCRtesting rates,as most of the states exhibited lower share of the test.

The States were advised to keep a close watch on the number of hospitalisation and deaths.“It is important to analyse at the State-level the proportion of vaccinated and unvaccinated of the hospitalised cases, the deaths and those on ventilators and oxygen support”, Mr. Mandaviya advised.

Utilisation of ECRP-II funds

He also urged all the States to fullyand effectivelyutilise the ECRP-II fundsfor strengthening the existing healthcare infrastructure and create new ones as perrequirement.

“As the located funds under ECRP-II shall lapse on 31stMarch 2022,Stateswere requested to review the progress on a regular basis, as thishealthcare infrastructure will not only be utilised during the present pandemic, but will serve the people in the future too,’’ stated a press note issued by the Health Ministry after the meeting.

The Minister asked the States to complete the installation and commissioning of PSA plants, LMO storage tanks and MGPSexpeditiously.

Highlighting vaccinationasa critical tool of pandemic management, he wanted the States toaccelerate vaccination of all eligible population, especially of the 15-17 age group and those whose second dose is due.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.